Quidel Corporation to Buy Diagnostic Hybrids for $130 Million
Quidel Corp announces the signing of a definitive agreement to acquire privately held Diagnostic Hybrids, Inc. for approximately $130 million in cash.
Read MorePosted by Clinical Lab Products | Jan 12, 2010 | Miscellaneous |
Quidel Corp announces the signing of a definitive agreement to acquire privately held Diagnostic Hybrids, Inc. for approximately $130 million in cash.
Read MorePosted by Clinical Lab Products | Jan 7, 2010 | Miscellaneous |
ADA Recommends A1C as Diagnostic Test for Diabetes The American Diabetes Association‘s new Clinical Practice Recommendations being published as a supplement to the January issue of Diabetes Care call for the addition of the A1C test as a means o
Read MorePosted by Clinical Lab Products | Jan 6, 2010 | Miscellaneous |
Bio-Rad Laboratories Inc has announced that it has completed the purchase of certain diagnostics businesses of Biotest AG, including its diagnostics products in the areas of blood transfusion testing, transplantation, and infectious diseases for 45 million euros.
Read MorePosted by Clinical Lab Products | Jan 5, 2010 | Miscellaneous |
Bio-Rad Laboratories Inc and and Axis-Shield plc, an international in-vitro diagnostics (IVD) company, announced the launch of Bio-Rad’s BioPlex 2200 Anti-CCP test for the early detection of rheumatoid arthritis.
Read MorePosted by Clinical Lab Products | Dec 22, 2009 | Miscellaneous |
Rates of 2009 H1N1 influenza virus testing in the US have declined more than 75% since their peak in late October, suggesting that the second wave of virus infection may be coming to an end, according to a new report by Quest Diagnostics.
Read More